Naouel Tennoune

Title: Naouel Tennoune: Pioneering Innovations in Appetite Regulation

Introduction

Naouel Tennoune, a talented inventor based in Rouen, France, has made significant contributions to the field of appetite regulation through her innovative pharmaceutical and food compositions. With two notable patents to her name, Naouel's work focuses on addressing eating disorders and obesity, highlighting her commitment to improving health outcomes for individuals in need.

Latest Patents

Naouel's latest patents showcase her ground-breaking research. The first patent, titled "Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof," revolves around a method of inducing satiation through the administration of ClpB protein or bacteria expressing this protein. This invention aims to enhance the satiation experience, thereby assisting individuals in managing their appetite effectively.

The second patent, "Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH," expands on the role of ClpB expressing bacteria in relation to obesity and eating disorders. This patent details the therapeutic use of specific ClpB protein expressions, alongside compositions that include antibiotics targeting ClpB expressing bacteria and probiotics that do not express this protein. Additionally, it encompasses diagnostic tools to identify subjects likely to respond to treatment methods for eating disorders, as well as methods of immunization against such disorders.

Career Highlights

Naouel has worked with esteemed institutions, notably the National Institute of Health and Medical Research (Institut National De La Sante Et De La Recherche Medicale) and the University Hospital of Rouen (Centre Hospitalier Universitaire De Rouen). Her positions within these organizations have allowed her to conduct impactful research that bridges the gap between clinical needs and innovative solutions.

Collaborations

Throughout her career, Naouel has collaborated with prominent researchers, including Serguei Fetissov and Jonathan Breton. These partnerships have facilitated the development of new approaches and have contributed to her understanding of the complexities surrounding appetite regulation and eating disorders.

Conclusion

Naouel Tennoune's pioneering work in developing pharmaceutical and food compositions to induce satiation and combat eating disorders stands as a testament to her innovative spirit and dedication to improving public health. With her patents, she is paving the way for novel solutions to long-standing challenges in appetite regulation, making her a noteworthy figure in the realm of invention and research.